相似文献
1
Racial and Ethnic Representation in US Clinical Trials of New Drugs and Biologics, 2015-2019.
JAMA. 2021 Dec 7;326(21):2201-2203. doi: 10.1001/jama.2021.16680.
2
Racial and Ethnic Diversity in Studies Funded Under the Best Pharmaceuticals for Children Act.
Pediatrics. 2021 May;147(5). doi: 10.1542/peds.2020-042903. Epub 2021 Apr 12.
3
Diversity in clinical trials in Europe and the USA: a review of a pharmaceutical company's data collection, reporting, and interpretation of race and ethnicity.
Ann Oncol. 2023 Dec;34(12):1194-1197. doi: 10.1016/j.annonc.2023.09.3107. Epub 2023 Sep 27.
4
Racial and Ethnic Representation of Participants in US Clinical Trials of New Drugs and Biologics.
JAMA. 2022 Mar 8;327(10):985. doi: 10.1001/jama.2022.0875.
5
Racial and Ethnic Representation of Participants in US Clinical Trials of New Drugs and Biologics-Reply.
JAMA. 2022 Mar 8;327(10):985. doi: 10.1001/jama.2022.0878.
6
An Evaluation of Novel Oncology Approvals with a PMR/C for Assessing Data in Racial and Ethnic Populations Underrepresented in Premarket Clinical Trials.
Clin Cancer Res. 2024 Aug 15;30(16):3388-3394. doi: 10.1158/1078-0432.CCR-24-0852.
7
Classification of race and ethnicity: implications for public health.
Annu Rev Public Health. 2003;24:83-110. doi: 10.1146/annurev.publhealth.24.100901.140927. Epub 2002 Oct 23.
8
Racial, Ethnic, and Gender Representation in Leadership Positions at National Cancer Institute-Designated Cancer Centers.
JAMA Netw Open. 2021 Jun 1;4(6):e2112807. doi: 10.1001/jamanetworkopen.2021.12807.
9
Association of the COVID-19 Pandemic With Estimated Life Expectancy by Race/Ethnicity in the United States, 2020.
JAMA Netw Open. 2021 Jun 1;4(6):e2114520. doi: 10.1001/jamanetworkopen.2021.14520.
10
Trends in Racial and Ethnic Disparities in COVID-19 Hospitalizations, by Region - United States, March-December 2020.
MMWR Morb Mortal Wkly Rep. 2021 Apr 16;70(15):560-565. doi: 10.15585/mmwr.mm7015e2.
引用本文的文献
1
Reporting of Sociodemographic and Clinical Characteristics in US-Based Randomized Clinical Trials of Deprescribing Interventions for Older Adults.
Drugs Aging. 2025 Jul 5. doi: 10.1007/s40266-025-01226-0.
2
Representation of Women, Older Adults, and Racial and Ethnic Minoritized Patients in Pivotal Trials for US Food and Drug Administration Novel Oncology Therapeutic Approvals, 2012-2021: Bright Spot Trials and Trends Over Time.
JCO Oncol Pract. 2025 Jun 10:OP2400563. doi: 10.1200/OP-24-00563.
3
Auricular Point Acupressure for Older Adults with Chronic Low Back Pain: A Randomized Controlled Trial.
Pain Med. 2025 Mar 27. doi: 10.1093/pm/pnaf035.
4
Navigating the Path to Inclusion: Understanding Barriers and Facilitators to Clinical Trial Participation Among Chinese Older Adults in the United States with Multimorbidity.
J Gen Intern Med. 2025 Feb;40(2):393-401. doi: 10.1007/s11606-024-09162-2. Epub 2024 Nov 4.
5
A Descriptive, Post Hoc Analysis of Efficacy and Safety of Risankizumab in Diverse Racial and Ethnic Patient Populations With Moderate-to-Severe Psoriasis.
Dermatol Ther (Heidelb). 2024 Oct;14(10):2877-2887. doi: 10.1007/s13555-024-01268-z. Epub 2024 Oct 2.
6
Variations in racial and ethnic groups' trust in researchers associated with willingness to participate in research.
Humanit Soc Sci Commun. 2023;10. doi: 10.1057/s41599-023-01960-z. Epub 2023 Aug 2.
7
A Multidisciplinary Assessment of ChatGPT's Knowledge of Amyloidosis: Observational Study.
JMIR Cardio. 2024 Apr 19;8:e53421. doi: 10.2196/53421.
8
Racial and ethnic diversity in global neuroscience clinical trials.
Contemp Clin Trials Commun. 2024 Jan 4;37:101255. doi: 10.1016/j.conctc.2024.101255. eCollection 2024 Feb.
9
Allyship to Advance Diversity, Equity, and Inclusion in Otolaryngology: What We Can All Do.
Curr Otorhinolaryngol Rep. 2023 Sep;11(3):201-214. doi: 10.1007/s40136-023-00467-0. Epub 2023 Jul 4.
10
British South Asian ancestry participants views of pharmacogenomics clinical implementation and research: a thematic analysis.
Pharmacogenomics J. 2023 Nov;23(6):185-194. doi: 10.1038/s41397-023-00317-8. Epub 2023 Nov 1.
本文引用的文献
1
Demographic diversity of participants in Pfizer sponsored clinical trials in the United States.
Contemp Clin Trials. 2021 Jul;106:106421. doi: 10.1016/j.cct.2021.106421. Epub 2021 Apr 30.
2
Inclusion, analysis, and reporting of sex and race/ethnicity in clinical trials: have we made progress?
J Womens Health (Larchmt). 2011 Mar;20(3):315-20. doi: 10.1089/jwh.2010.2469. Epub 2011 Feb 25.
Zotero 插件